In HIV hyperendemic sub-Saharan African communities, particularly in southern Africa, the likelihood of achieving the Sustainable Development Goal of ending the tuberculosis (TB) epidemic by 2030 is low, due to lack of cost-effective and practical interventions in population settings. We used one of Africa's largest population-based prospective cohorts from rural KwaZulu-Natal Province, South Africa, to measure the spatial variations in the prevalence of recently-diagnosed TB disease, and to quantify the impact of community coverage of antiretroviral therapy (ART) on recently-diagnosed TB disease. We collected data on TB disease episodes from a population-based sample of 41,812 adult individuals between 2009 and 2015. Spatial clusters ('hot...
Objective To investigate the impact of antiretroviral therapy (ART) on long-term population-level tu...
Scale-up of antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection has reduce...
In 2020, Tuberculosis (TB) was the second-leading cause of death by a single infectious agent, trail...
In HIV hyperendemic sub-Saharan African communities, particularly in southern Africa, the likelihood...
SETTING: Incidencerates of tuberculosis (TB) in South Africa are among the highest in the world, and...
SETTING: Incidencerates of tuberculosis (TB) in South Africa are among the highest in the world, and...
BACKGROUND: South Africa remains the country with the greatest burden of HIV-infected individuals an...
OBJECTIVE : To identify spatial clusters with unusually high levels of MDR-TB, which are highly unli...
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality globally. Scale-up of e...
OBJECTIVES: Antiretroviral therapy (ART) and isoniazid preventive therapy (IPT) are known to have a ...
CITATION: Sloot, R. et al. 2018. Variation in HIV prevalence and the population-level effects of ant...
CAPRISA, 2014.Background: The challenge of early tuberculosis (TB) infection among rural patients ac...
BACKGROUND : Extensively drug-resistant tuberculosis (XDR-TB) incidence is driven by transmission of...
Introduction Although HIV infection increases the likelihood of developing TB, evidence suggests t...
To investigate the impact of antiretroviral therapy (ART) on long-term population-level tuberculosis...
Objective To investigate the impact of antiretroviral therapy (ART) on long-term population-level tu...
Scale-up of antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection has reduce...
In 2020, Tuberculosis (TB) was the second-leading cause of death by a single infectious agent, trail...
In HIV hyperendemic sub-Saharan African communities, particularly in southern Africa, the likelihood...
SETTING: Incidencerates of tuberculosis (TB) in South Africa are among the highest in the world, and...
SETTING: Incidencerates of tuberculosis (TB) in South Africa are among the highest in the world, and...
BACKGROUND: South Africa remains the country with the greatest burden of HIV-infected individuals an...
OBJECTIVE : To identify spatial clusters with unusually high levels of MDR-TB, which are highly unli...
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality globally. Scale-up of e...
OBJECTIVES: Antiretroviral therapy (ART) and isoniazid preventive therapy (IPT) are known to have a ...
CITATION: Sloot, R. et al. 2018. Variation in HIV prevalence and the population-level effects of ant...
CAPRISA, 2014.Background: The challenge of early tuberculosis (TB) infection among rural patients ac...
BACKGROUND : Extensively drug-resistant tuberculosis (XDR-TB) incidence is driven by transmission of...
Introduction Although HIV infection increases the likelihood of developing TB, evidence suggests t...
To investigate the impact of antiretroviral therapy (ART) on long-term population-level tuberculosis...
Objective To investigate the impact of antiretroviral therapy (ART) on long-term population-level tu...
Scale-up of antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection has reduce...
In 2020, Tuberculosis (TB) was the second-leading cause of death by a single infectious agent, trail...